Daniel Chao, MD, PhD, Janssen - Johnson & Johnson

The Coast to Coast Journey from Academic Research to Janssen Pharmaceuticals with Daniel Chao, MD, PhD

By Priscilla Villarreal | January 25, 2022

PODCAST EPISODE 314 Click here to watch the video version of this podcast. Daniel Chao, MD, PhD, spent a lot of years in the lab…

Read More
Sharon Bakalash, MD, PhD, CBA - Panel

Here’s What’s New in Drug Delivery

By Priscilla Villarreal | January 19, 2022

PODCAST EPISODE 313 Click here to watch the video version of this podcast. A new generation of drug-delivery technology is emerging, with new refillable, absorbable, and…

Read More
Brian Strem - Kiora Pharmaceuticals

Passionate Pursuits With Kiora Pharmaceuticals Brian Strem

By Priscilla Villarreal | January 12, 2022

PODCAST EPISODE 312 Click here to watch the video version of this podcast. Brian Strem, president and CEO of Kiora Pharmaceuticals, didn’t plan to become…

Read More

Calculating Both Sides of the Doctor-Patient Equation, with Diana Driscoll, OD

By Priscilla Villarreal | December 8, 2021

PODCAST EPISODE 309 Click here to watch the video version of this podcast. Even the most experienced physicians encounter patients with conditions they can’t solve…

Read More

Following Intellectual Passions, With Dr. Baruch Kupperman

By Jackie Wengrod | September 29, 2021


Read More

Despite Mixed Trial Results and Stock Plunge, Apellis Keeps Commitment to Lead Candidate Pegcetacoplan

By Rich Kirkner | September 15, 2021

Despite a sharp dive in its stock price a day after reporting mixed topline results from two Phase III clinical trials of its lead candidate…

Read More

From Big Pharma Lawyer to Eye Care Disruptor: IACTA Pharmaceuticals Founder & CEO Damon Burrows

By Jackie Wengrod | September 15, 2021

PODCAST EPISODE 297 Click here to watch the video version of this podcast. Damon Burrows isn’t a scientist. And he didn’t start IACTA Pharmaceuticals, an…

Read More

NIH Awards Amydis $3 Million Grant Award for Novel Amyloid Beta Retinal Tracer Applicable to CNS Diseases

By Conni Bergmann Koury | August 10, 2021

Amydis is developing novel small-molecule contrast agents that aim to enable the direct visualization of central nervous system (CNS) disease-related biomarkers in the retina. The…

Read More

Stem Cell-Engineered Implant for Geographic Atrophy Shows Promise, Long-Term Survival of Cells in Early Trial

By Conni Bergmann Koury | August 3, 2021

A number of companies are developing drug treatments for geographic atrophy, the result of advanced dry age-related macular degeneration (AMD), for which no approved treatments…

Read More

Apellis Building on Its Platform with APL-2 for Geographic Atrophy

By Steve Lenier | June 8, 2021

Weeks after receiving Food and Drug Administration approval for its complement factor 3 (C3) inhibitor pegcetacoplan, now known as Empaveli, to treat adults who have…

Read More
OIS Digital Innovation Showcase

The Four Trends Driving the Digital Space

By Rich Kirkner | May 25, 2021

Money is pouring into digital health at a record clip – $6.7 billion in the first quarter this year, the investment firm Rock Health reports.…

Read More

Innovega is Moving Quickly in Augmented- and Virtual-Reality Space

By Steve Lenier | May 19, 2021

In 2020 Innovega, which is headquartered in Bellevue, WA, and has development facilities in San Diego, was recognized in a listing of “Cool Companies” selected…

Read More


Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.